Replies to post #1501 on Benitec Biopharma Ltd (BNTC)

[Blane]

Thanks, Bellweather. Yeah, for most of us, the ability to switch was free at the initial ADR offering. But interesting to see the slight difference in value.

Interesting to note on the side, if they give the go ahead for the next two patients in this second cohort, it pretty much means they more than likely will get the go ahead for cohort 3. Exciting times right now for Benitec holders!

[68-Tele]

I was in a Scottrade office and he was reading it to me, maybe it was just Scottrade phasing it out but I remember 2016-2017
as the date.

From Benitec's web site:
"For some time there has been an unsponsored ADR program in the U.S. with Benitec shares trading as BNIKF. Benitec has no control over this unsponsored ADR program.

The unsponsored ADR program will remain in place, however shareholders of BNIKF will be able to transfer to the new sponsored ADR (BTEBY). Holders of BNIKF ADRs may transfer their holding to the new sponsored ADRs (BTEBY) without attracting an issuance fee by BNY Mellon for transactions before July 31, 2014.